Paul C. Grint
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul C. Grint
Paul C. Grint is recorded as CEO at Armata Pharmaceuticals, Inc. (ARMP). The proxy statement of Armata Pharmaceuticals, Inc. reports total compensation of $694,770 for Paul C. Grint in fiscal 2019, including a base salary of $170,928. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Armata Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Deborah Birx CEO
- Deborah L. Birx CEO, Board Member
- Dr. Deborah Birx CEO, Board Member
- Richard J. Bastiani Chairman
- David House CFO
- Julianne Averill CFO
- Richard Rychlik CFO
- Erin Butler Chief Accounting Officer
- Daniel Gilmer Board Member
- Dr. Daniel Gilmer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Armata Pharmaceuticals, Inc. (ARMP) | Former Chief Executive Officer | $170,928 | $694,770 |
| 2018 | Armata Pharmaceuticals, Inc. (ARMP) | Former Chief Executive Officer | $475,000 | $618,000 |
Recent activity
No call appearances or filed executive changes recorded yet.